Irritable bowel syndrome and colon cancer: A meta-analysis
World Journal of Clinical Cases · 06.08.2026 · 14 (22)
DOI: 10.12998/wjcc.121062 ↗Kurz gefasst
Metaanalyse in der Zeitschrift World Journal of Clinical Cases, online erschienen am 06.08.2026. Verfasst von Hyder Osman Mirghani und 1 weiteren Autor:innen. Die Arbeit nennt 37 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder that negatively affects quality of life and psychological well-being. Because IBS is diagnosed using symptom-based criteria such as the Rome criteria, its clinical manifestations may overlap with those of colon cancer, raising concerns about potential misdiagnosis. AIM To evaluate the association between IBS and colon cancer. METHODS A systematic search of PubMed/MEDLINE, Web of Science, and Google Scholar was conducted for English-language articles published up to January 2026. The search was performed between December 2025 and January 2026 using the keywords “irritable bowel syndrome”, “colon cancer”, “colorectal cancer”, “rectosigmoid cancer”, and “gastrointestinal cancer”, combined with the Boolean operators “AND” and “OR”. Through this, a total of 1013 records were identified. After removing duplicates, 469 articles remained; of those remaining articles, 79 full-text articles were screened for eligibility and 9 studies were included in the final meta-analysis. RESULTS The pooled analysis showed no significant association between IBS and colon cancer compared with controls [odds ratio (OR) = 1.05, 95%CI: 0.57-1.94]. Sensitivity analysis after removal of outliers yielded similar results (OR = 1.25, 95%CI: 0.86-1.81). Furthermore, 3 longitudinal studies demonstrated no association between IBS and colon cancer (risk ratio = 1.00, 95%CI: 1.00-1.00). CONCLUSION Overall, the findings indicate that IBS is not associated with an increased risk of colon cancer. These results support adherence to current guideline-based diagnostic criteria for IBS while maintaining appropriate clinical vigilance for alarm features suggestive of malignancy.
Zitieren
APA
Mirghani, H. O., & Alanazi, G. O. (2026). Irritable bowel syndrome and colon cancer: A meta-analysis. World Journal of Clinical Cases, 14(22). https://doi.org/10.12998/wjcc.121062
Vancouver
Mirghani HO, Alanazi GO. Irritable bowel syndrome and colon cancer: A meta-analysis. World Journal of Clinical Cases. 2026;14(22). doi:10.12998/wjcc.121062
BibTeX
@article{Mirghani2026,
author = {Mirghani, Hyder Osman and Alanazi, Ghadah Osman},
title = {Irritable bowel syndrome and colon cancer: A meta-analysis},
journal = {World Journal of Clinical Cases},
year = {2026},
volume = {14},
number = {22},
doi = {10.12998/wjcc.121062}
}
EUVIMED